Literature DB >> 28065600

Lysyl Oxidase 3 Is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation.

Li Ma1, Chao Huang2, Xiong-Jun Wang3, Dazhuan Eric Xin3, Li-Shun Wang3, Quanli C Zou3, Ya-Nan S Zhang3, Min-Dian Tan3, Yu-Mei Wang3, Ting C Zhao4, Devasis Chatterjee4, Rachel A Altura4, Chuangui Wang5, Yan S Xu6, Jing-Hua Yang6, Yong-Sheng Fan7, Bao-Hui Han8, Jianmin Si9, Xiaoren Zhang3, Jinke Cheng10, Zhijie Chang11, Y Eugene Chin12.   

Abstract

In mammalian cells, histone deacetylase (HDAC) and Sirtuin (SIRT) are two families responsible for removing acetyl groups from acetylated proteins. Here, we describe protein deacetylation coupled with deacetylimination as a function of lysyl oxidase (LOX) family members. LOX-like 3 (Loxl3) associates with Stat3 in the nucleus to deacetylate and deacetyliminate Stat3 on multiple acetyl-lysine sites. Surprisingly, Loxl3 N-terminal scavenger receptor cysteine-rich (SRCR) repeats, rather than the C-terminal oxidase catalytic domain, represent the major deacetylase/deacetyliminase activity. Loxl3-mediated deacetylation/deacetylimination disrupts Stat3 dimerization, abolishes Stat3 transcription activity, and restricts cell proliferation. In Loxl3-/- mice, Stat3 is constitutively acetylated and naive CD4+ T cells are potentiated in Th17/Treg cell differentiation. When overexpressed, the SRCR repeats from other LOX family members can catalyze protein deacetylation/deacetylimination. Thus, our findings delineate a hitherto-unknown mechanism of protein deacetylation and deacetylimination catalyzed by lysyl oxidases.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28065600     DOI: 10.1016/j.molcel.2016.12.002

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  21 in total

1.  Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV.

Authors:  Alberto J López-Jiménez; Trayambak Basak; Roberto M Vanacore
Journal:  J Biol Chem       Date:  2017-09-01       Impact factor: 5.157

2.  The Expression Patterns and Roles of Lysyl Oxidases in Aortic Dissection.

Authors:  Xin Yi; Yi Zhou; Yue Chen; Xin Feng; Chang Liu; Ding-Sheng Jiang; Jing Geng; Xiaoyan Li; Xuejun Jiang; Ze-Min Fang
Journal:  Front Cardiovasc Med       Date:  2021-07-07

Review 3.  Lactylation: a Passing Fad or the Future of Posttranslational Modification.

Authors:  Qi Xin; Hai Wang; Qinglin Li; Sinan Liu; Kai Qu; Chang Liu; Jingyao Zhang
Journal:  Inflammation       Date:  2022-02-27       Impact factor: 4.657

4.  Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability.

Authors:  Patricia G Santamaría; Alfredo Floristán; Bárbara Fontanals-Cirera; Alberto Vázquez-Naharro; Vanesa Santos; Saleta Morales; Lourdes Yuste; Héctor Peinado; Antonio García-Gómez; Francisco Portillo; Eva Hernando; Amparo Cano
Journal:  Cell Death Differ       Date:  2017-12-11       Impact factor: 15.828

Review 5.  Molecular Insights Into Lysyl Oxidases in Cartilage Regeneration and Rejuvenation.

Authors:  Weiping Lin; Liangliang Xu; Gang Li
Journal:  Front Bioeng Biotechnol       Date:  2020-04-30

Review 6.  STAT3, a Master Regulator of Anti-Tumor Immune Response.

Authors:  Cédric Rébé; François Ghiringhelli
Journal:  Cancers (Basel)       Date:  2019-08-30       Impact factor: 6.639

7.  Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia.

Authors:  Xiang-Hong Xu; Yuanhui Jia; Xinyao Zhou; Dandan Xie; Xiaojie Huang; Linyan Jia; Qian Zhou; Qingliang Zheng; Xiangyu Zhou; Kai Wang; Li-Ping Jin
Journal:  Exp Mol Med       Date:  2019-02-21       Impact factor: 8.718

8.  LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP.

Authors:  Lin Hu; Jing Wang; Yunliang Wang; Linpeng Wu; Chao Wu; Bo Mao; E Maruthi Prasad; Yuhong Wang; Y Eugene Chin
Journal:  Cell Commun Signal       Date:  2020-09-10       Impact factor: 5.712

Review 9.  Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity.

Authors:  Chin-Jui Wu; Vignesh Sundararajan; Bor-Ching Sheu; Ruby Yun-Ju Huang; Lin-Hung Wei
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

Review 10.  Host Transcription Factors in Hepatitis B Virus RNA Synthesis.

Authors:  Kristi L Turton; Vanessa Meier-Stephenson; Maulik D Badmalia; Carla S Coffin; Trushar R Patel
Journal:  Viruses       Date:  2020-01-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.